The HER2 positivity rates for bladder carcinomas, gallbladder, extrahepatic cholangiocarcinoma, cervical, uterine, and testicular cancers was 12.4%, 9.8%, 6.3%, 3.9%, 3.0%, and 2.4%, respectively [28]. Here, ERBB2 is linked to urinary bladder carcinoma.